To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

Completed · Phase 2

Conditions studied: Diabetes Mellitus, Type 1

In brief

To examine the lung when people with diabetes take an inhaled form of insulin, compared to subcutaneous insulin.

Key facts

Study ID

NCT00143104

Run by

Pfizer

People needed

20

Starts

2004-12-01

Expected to finish

2006-10-01

Last updated by the study team

2008-03-11

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 1 Diabetes Mellitus
• Normal lung function

You may not qualify if…

• Smokers

Where it is running

• Pfizer Investigational Site — Glendale, Arizona, United States
• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.